NCT07816042

Brief Summary

The adenoids, also known as pharyngeal tonsils, are the peripheral immune organs of the human body and are located at the junction of the nasopharyngeal parietal and posterior walls. The adenoids represent the first defense portal of the respiratory tract and the earliest site of exposure to various antigens by inhalation or ingestion This can result in adenoid hypertrophy (AH) due to repeated stimulation by various antigens and their own inflammation (1) . AH is the chronic enlargement of the adenoids usually accompanied by recurrent infections. Adenoids which are enlarged are capable of becoming practically the ping pong ball sized and wholly obstruct airflow in the course of nasal cavities (2) . AH is commonly encountered in children and is a well-recognized cause of nasal obstruction. Typically, the tissue undergoes involution during adolescence, and its persistence into adulthood is considered unusual. However, AH in adolescents is thought to be a persistence of untreated AH of childhood (3) In such cases, persistent adenoid hypertrophy may continue to cause chronic nasal obstruction and prolonged mouth breathing. Mouth breathing alters the normal functional balance between the tongue, lips, and buccal muscles, which may contribute to narrowing of the maxillary arch and development of a high-arched palate during childhood growth. If adenoid hypertrophy and nasal obstruction remain untreated, these functional and structural changes may persist into adolescence (4) . As the hard palate forms the floor of the nasal cavity, a high-arched palate and associated maxillary changes may alter the shape and available space of the nasal cavity. Such anatomical changes may

  • may influence the configuration of the nasal septum, particularly during the growing years, 2 providing a possible structural link between long-standing adenoid hypertrophy and septal deviation (5) Despite the recognized effects of chronic adenoid obstruction on nasal breathing and craniofacial development, evidence specifically addressing whether long-standing untreated AH is associated with septal deviation remains limited. so, this study aims to investigate the clinicoradiological correlation between long-standing untreated AH and nasal septal deviation in adolescent

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
14mo left

Started Oct 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Dec 2027

First Submitted

Initial submission to the registry

September 7, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

September 11, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 7, 2026

Last Update Submit

September 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Degree of nasal septal deviation in relation to the presence and size of longstanding untreated adenoid hypertrophy

    baeline

Study Arms (1)

study group

patients with chronic nasal obstruction

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

patients with chronic nasal obstruction

You may qualify if:

  • Age 10 to18 years. Both sexes. Adolescents with long standing untreated adenoid hypertrophy. Presence of symptoms suggestive of chronic nasal obstruction, such as mouth breathing, nasal obstruction, or snoring

You may not qualify if:

  • Previous adenoidectomy or nasal surgery. History of significant nasal trauma or nasal fracture. Congenital craniofacial anomalies. Chronic sinonasal diseases that may independently cause significant nasal obstruction. Patients who disagreed to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
residant doctor at Assiut university hospital

Study Record Dates

First Submitted

September 7, 2026

First Posted

September 11, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

September 11, 2026

Record last verified: 2026-09